AARP Report Finds Sky-High Drug Prices

Escalating drug prices have been making the news in recent months. In particular, the exorbitant price tags of two brand-name drugs used to treat Hepatitis C — Solvaldi and Harvoni — have ignited intense controversy. I talked with Leigh Purvis, director of health services research, AARP Public Policy Institute, and coauthor of AARP’s Rx Price Watch Report: Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans, 2006-2013 about the trend in rising drug prices and what …

Why Are Some Generic-Drug Prices Soaring?

Inexpensive generic drugs have helped millions of Americans save money on brand-name medication, but lately soaring prices on some longtime generics are prompting investigations into this pricing U-turn by pharmaceutical companies. In addition, a a new AARP drug-pricing report shows retail prices for brand-name prescription drugs continue to increase. The debate over some generic price hikes has spurred the Senate Subcommittee on Primary Health and Aging to hold a hearing to review pricing on a dozen generics, and the Department …

Generic Drug Recall Raises More Questions

Last week’s surprise announcement by the U.S. Food and Drug Administration that a popular generic antidepressant is not equivalent to the original drug also raises concerns doctors and patients have had about other generic versions of common medications. In an about-face, the FDA announced it had notified drug company Teva Pharmaceuticals to stop shipping Budeprion XL 300 milligrams, a copycat of the extended-release antidepressant Wellbutrin XL 300 milligrams, and to remove it from U.S. shelves. The highly unusual decision contradicts …